Insider Transactions in Q3 2023 at Chinook Therapeutics, Inc. (KDNY)
Insider Transaction List (Q3 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 11
2023
|
Andrew James King Chief Scientific Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
19,157
-100.0%
|
-
|
|
Aug 11
2023
|
Mahesh Krishnan Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
1,275
-100.0%
|
-
|
|
Aug 11
2023
|
Dolca Thomas Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
13,300
-100.0%
|
-
|
|
Aug 11
2023
|
Eric Bjerkholt Chief Financial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
39,371
-100.0%
|
-
|
|
Aug 11
2023
|
Davis Jerel Director |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
3,035,207
-100.0%
|
-
|
|
Aug 11
2023
|
Davis Jerel Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
447,013
-100.0%
|
-
|
|
Aug 11
2023
|
Eric Dobmeier President, CEO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
301,138
-100.0%
|
-
|
|
Aug 11
2023
|
Tom Frohlich Chief Operating Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
150,777
-100.0%
|
-
|
|
Aug 11
2023
|
William Mariner Greenman Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
23,643
-100.0%
|
-
|
|
Aug 11
2023
|
Michelle Renee Griffin Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
3,300
-100.0%
|
-
|
|
Aug 11
2023
|
Srinivas Akkaraju Director |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
5,161,888
-100.0%
|
-
|
|
Aug 11
2023
|
Srinivas Akkaraju Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
3,300
-100.0%
|
-
|
|
Aug 01
2023
|
Andrew James King Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
1,168
-5.75%
|
$45,552
$39.03 P/Share
|
|
Jul 29
2023
|
Andrew James King Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,333
+14.09%
|
-
|